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Efficacy of Surgical VS. NoN-Surgical TrEaTMENT of carPal TuNNEl 
SyNdroME (cTS): a SySTEMaTic rEViEw
Goyal R, Kaneria J, Rai MK, Bhutani MK, Singh R, Rana P
Tata Consultancy Services, Mumbai, India
Objectives: To conduct a systematic review to compare the efficacy of surgical 
versus non-surgical treatment of carpal tunnel syndrome (CTS). MethOds: We 
searched Embase, Medline & Cochrane databases from January 2000 to June 2015 
and included all randomised controlled trials comparing any surgical versus non-
surgical therapies in patients with CTS. Two authors independently assessed the 
eligibility of the trials and performed all the necessary steps of a systematic review. 
A qualitative analysis of the results was done. Results: From the 112 studies 
retrieved, five studies reached the stage of data extraction. Three studies compared 
decompressive surgery with local steroid injection, one study compared surgical 
versus non-surgical (hand therapy and ultrasound) and the last study compared 
surgery versus splinting, respectively. The studies included 95 wrists, 163 wrists, 50 
patients, 116 patients and 176 patients. The study with 50 patients reported that at 
20 weeks patients who underwent surgery had greater symptomatic improvement 
than those who were injected with steroids. The mean improvement in GSS after 20 
weeks was 24.2 (SD 11.0) in the surgery group vs 8.7 (SD 13.0) in the injection group 
(p < 0.001). Similarly, the other two trials comparing surgery with steroid injection 
reported that surgery has additional benefits in improving CTS. The trial comparing 
surgery with splinting reported a success rate of 90% with surgery as compared to 
75% with splinting. The trial with surgery versus non-surgery revealed a signifi-
cant 12-month adjusted advantage for surgery in function (CTSAQ function score: 
Delta -0.40, 95% CI 0.11-0.70, p= 0.0081) and symptoms (CTSAQ symptom score: 0.34, 
0.02-0.65, p= 0.0357). cOnclusiOns: Surgical treatment of CTS relieves symptoms 
significantly better compared to non-surgical treatment. Further, the surgical treat-
ment was a better option as compared to local steroid injections and splinting.
PMS11
uSiNg acTiVE TEchNiquES To haNdlE chroNic low Back PaiN cauSEd By 
SEdENTary work
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Objectives: Chronic low back pain (cLBP) is a key issue for health care and society. 
The purpose of this study was to evaluate the efficacy of a 3-months long training 
programme by examining the muscular strength, the range of motion, the muscle-
stretching, the pain and the functional development at sedentary workers with 
cLBP. MethOds: The examination was carried out in Zalaegerszeg in 2014. Thirty 
patients were involved (30-60y) who had cLBP because of sedentary work for many 
years. The participants received core stability training and traditional active and 
passive stretching exercises integrated with myofascial release technique. Data 
collection: 1) core strength and stability tests (DAVID 110,130 and modified plank-
tests), 2) lumbar spine range of motion (Zebris-system), 3) muscle stretching (David-
conception), 4) pain and functionality (Visual Analog Scale, Roland-Morris Scale) 
and 5) general health status (physical examination, discharge report, self-made 
questionnaire). Descriptive statistics, t-test and chi2–test were used (IBM SPSS 
19v.). Results: The trunk muscle forces (flexors p= 0.003, extensors p= 0.008) and 
the modified plank tests (prone and side position p= 0.001, supine position p= 0.042) 
shown significant improvement. The spine range of motion shown significant 
improvements (p= 0.001). The level of pain decreased significantly (p= 0.001), simi-
lar to the Roland-Morris Index (p= 0.001). The muscle stretching tests represented 
important but not significant changes. cOnclusiOns: Present study provides 
further evidence of the effectiveness of core stabilisation and muscle stretching 
techniques in cLBP. It would be worthwhile to continue this study involving more 
patients with long follow-up emphasizing the myofascial release techniques.
PMS12
EffEcTiVENESS of alloPuriNol iN achiEViNg aNd SuSTaiNiNg TargET 
SEruM uraTE: aN aNalySiS of a NaTioNal iNTEgraTEd u.S. hEalThcarE 
SySTEM
Singh Ja, Yang S
UAB SCHOOL OF MEDICINE, Birmingham, AL, USA
Objectives: To comprehensively assess as to which patient, comorbidity, physi-
cian, system, health care access and disease factors are associated with the abil-
ity to achieve and maintain target serum urate (sUA) with allopurinol in patients 
with gout. MethOds: We used National VA national databases from 2002-2012. 
Patients were eligible if they had ≥ 2 outpatient or ≥ 1 inpatient encounters with 
an International Classification of Diseases-ninth version (ICD-9) code 274.xx for 
gout, and met 12-month observability rule. Index allopurinol use was defined as 
the filling of a new allopurinol prescription with no allopurinol exposure in the 
previous 121 days. Treatment successes were defined as the achievement of: (1) post-
index sUA < 6 mg/dl; and (2) post-index sUA < 6 mg/dl that was sustained. Results: 
41,153 unique patients with 47,072 episodes contributed to analyses of achieving 
target sUA (success 1) and 17,402 unique patients with 18,323 episodes to achiev-
ing and maintaining target sUA (success 2). In multivariable-adjusted models, the 
following were associated with significantly higher odds of both successes 1 and 
2: older age, normal BMI (18.5-25 kg/m2), currently married, Deyo-Charlson index 
score of 0, main provider being a physician, rheumatologist as the main provider 
rather than non-rheumatologist, Midwest location for the health care facility, a 
lower hospital bed size, service-connection conditions of 50% or more, longer dis-
tance to the nearest VA facility, lower pre-index sUA, higher allopurinol start and 
end dose, higher allopurinol adherence and recommended or fast allopurinol dose 
escalation. cOnclusiOns: In this study, we identified several important factors 
associated with achieving and maintaining sUA < 6 mg/dl. This new knowledge 
provides several new potential modifiable targets for improving the ability to lower 
serum urate with allopurinol pharmacotherapy and sustain a therapeutic target in 
patients with gout.
PMS7
rEducTioN iN c-rEacTiVE ProTEiN wiTh Biologic drugS iN rhEuMaToid 
arThriTiS aNd SPoNdyliTiS PaTiENTS iN gErMaN rhEuMaTologiST 
PracTicES
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IMS Health, Frankfurt am Main, Germany
Objectives: C-reactive protein (CRP) is one of the markers of inflammation 
in the body and a predictor of treatment outcome in patients with rheumatoid 
arthritis (RA) treated with biologic drugs. CRP levels > 10 mg/L are associated 
with very high cardiovascular risk. The aim of this study was to evaluate the 
difference in mean CRP levels before and after the initiation of biologic drugs in 
German rheumatologist practices. MethOds: German Disease Analyzer database 
including 34 rheumatologist practices was used. Data from 1,695 patients (mean 
age 52.1 years, 62% female) with a diagnosis of either rheumatoid arthritis (RA, 
ICD 10: M05, M06) or spondylitis (SP, ICD 10: M45, M46) with an initial biologic 
drug (etanercept, infliximab, adalimumab, golimumab) prescription (index date) 
between January 2004 and December 2013 and documented CRP levels within 
one year pre-index and one year post-index were identified and descriptively 
analyzed. Results: After the beginning of biologic drug therapy, CRP levels sig-
nificantly decreased from a mean of 17.7 mg/L before the index date to 11.7 mg/L 
after the index date (33.9% reduction, P< 0.001). In male patients, the relative 
difference in CRP levels was significantly higher than in female patients (39.0% 
versus 29.8%). The relative difference decreased with an age (49.5% in the age 
group < = 40 years, 31.4% in age group 41-50, 31.8 in age group 51-60 and 25.9 in 
age group > 60). cOnclusiOns: In this retrospective database study, performed 
among 1,695 patients with rheumatoid arthritis or spondylitis, we observed sig-
nificant reductions in CRP levels associated with male gender and younger age. 
These data have clinical relevance and significantly extend prior observational 
studies.
PMS8
cliNical EValuaTioN of aMriTadi guggulu aNd MaNdoora BhaSMa iN 
oSTEoarThriTiS PaTiENTS
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Objectives: To compare the combined effect of Amritadi Guggulu and Mandoora 
Bhasma with Trayodashanga Guggulu in Osteoarthritis patients. MethOds: A ran-
domized single blind clinical study with pre-test and post-test design was adopted 
where the patients were given treatment for a period of one month with follow-up. 
The inclusion criterion of the patients includes Osteoarthritis of knee joints, age 
group between 30 - 60 years, either gender, and irrespective of occupation and 
habitat. A total 307 patients of osteoarthritis of knee joint were selected from 
out-patient and inpatient departments of Muniyal Ayurveda Hospital, Manipal 
and grouped into A and B 154 and 153. Group A is given Amritadi Guggulu and 
Mandoora Bhasma and Group B is given Trayodashanga Guggulu. There were 4 
dropouts in group A and 3 in group B. The outcomes were assessed by using paired 
t-test and p< 0.05 was considered as statistically significant. Results: There was 
significant relief in Joint pain (83.74%), Joint tenderness (80.33%), Joint stiffness 
(82.83%), Swelling (63.39%), Crepitus (42.26%) and restriction of movement (74.50%) 
which was statistically significant (p< 0.001 ) in group A treated with Amritadi 
Guggulu and Mandoora Bhasma. In group B treated with Trayodashanga Guggulu 
was also observed relief in in Joint pain (47.80%), Joint tenderness (78.33%), Joint 
stiffness (61.61%), Swelling (64.28%), and Crepitus (41.86%) restriction of move-
ment (60.46%) which was statistically significant (p< 0.001). In group A there was 
statistically significant improvement in TLC (15.82%), Hemoglobin (11.58%) and 
ESR (47.71%) after treatment. In group B also observed statistically significant 
improvement in TLC (14.52%), Hemoglobin (6.01%) and ESR (43.69%) after treat-
ment. cOnclusiOns: Ayurveda management with administration of Amritadi 
Guggulu and Mandoora Bhasma showed good results when compared with 
patients treated with Trayodashanga Guggulu only. There was an increase in Hb% 
and decrease in ESR in these patients.
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Objectives: The thermal water of the City of Szigetvár, discovered in 1966, has a 
temperature of 62 oC when it reaches the surface and contains alkali-bicarbonatec 
with sodium chloride. The main objective is to explore the potential improvement in 
the quality of life and the effect of the thermal water as compared to warm tap water 
(placebo). It is assumed that the water with organic material content has a therapeuti-
cal effect. MethOds: Our research focuses on the therapeutic effect of this thermal 
water on patients suffering from rheumatic diseases, especially cox- and gonarthrosis, 
in a double–blind study. Sample size was n= 75. The treatment of 5 days /patient is per-
formed in Szigetvár spa in two randomly selected groups, using two tubs, and lasting 
30 minutes each time. Every patient is given tangentor and bath tub treatment alto-
gether 15 times. The methods used for the collection of data include the VAS, physical 
examination, document analysis and the Western Ontario and McMaster Universities 
Arthritis Index (WOMAC). Data were processed with the Microsoft Office Excel 2003 
and Windows SPSS 20.0 softwares, and the results were tested with the Mann-Whitney, 
the Wilcoxon and the khi-square tests. Results: Our data have shown a significant 
improvement (p= 0.035) in knee extension in the group treated with thermal water in 
contrast with the group treated with tap-water. The difference in life qualities was also 
significant measured by a Likert scale (p= 0.014). cOnclusiOns: The thermal water 
of the City of Szigetvár significantly improved the health status of patients suffering 
from rheumatic diseases in knee extension.
